Journal of Hebei University(Natural Science Edition) >

2016 , Vol. 36 >Issue 2: 148 - 154

DOI: https://doi.org/10.3969/j.issn.1000-1565.2016.02.007

Synthesis and cytotoxicity of indeno［1,2-b］quinoxalin-11-one oxime ethers

  • FENG Weipei ,
  • WANG Yingxing ,
  • LIU Siyuan ,
  • WANG Shuxiang ,
  • LI Shenghui
Expand
  • Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, College ofChemistry and Environmental Science, Hebei University, Baoding 071002, China

Received date: 2015-10-25

  Online published: 2016-03-25

Fold

Abstract

Ten novel indeno［1,2-b］quinoxalin-11-one oxime ethers(4A-4J)were synthesized by indeno［1,2-b］quinoxalin-11-one oxime, saturated dihalide, and piperidine or pyrrole, morpholine, and dibutylamine. Their cytotoxicity against HeLa, A549 and MCF-7 cell lines was evaluated by MTT assay. The results indicated that compounds 4A,4B,4E,4F, and 4J showed higher cytotoxicty than cisplatin against HeLa, A549, and MCF-7 cell lines. Among them, 4A, 4B and 4F exhibited 2 to 6 folds higher cytotoxicty than cisplatin. Both the length of oxime ether chain and the nature of the terminal group have important effects on the cytotoxicity. The cell cycle and apoptosis assays indicated that 4A could change the cells cycle ratio, and induce apoptosis. Our results suggest that indeno［1,2-b］quinoxalin-11-one oxime ether modified by pyrrole is a potential anti tumor precursor compound.

Key words： indeno［1,2-b］quinoxalin-11-one oxime derivatives; oxime ether; cytotoxicity

Cite this article

FENG Weipei , WANG Yingxing , LIU Siyuan , WANG Shuxiang , LI Shenghui . Synthesis and cytotoxicity of indeno［1,2-b］quinoxalin-11-one oxime ethers[J]. Journal of Hebei University(Natural Science Edition), 2016 , 36(2) : 148 -154 . DOI: 10.3969/j.issn.1000-1565.2016.02.007

References

[1] NOOLVI M N, PATEL H M, BHARDWAJ V, et al. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent[J]. Eur J Med Chem, 2011, 46: 2327-2346. DOI:10.1016/j.ejmech.2011.03.015.
[2] AL-RASHOOD S T, ABOLDAHAB I A, NAGI M N, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs[J]. Bioorg Med Chem, 2006, 14: 8608-8621. DOI:10.1016/j.bmc.2006.08.030.
[3] GOODWIN S, SMITH A F, HORNING E C. Alkaloids of Ochrosia elliptica labill[J]. J Am Chem Soc, 1959, 81: 1903-1908. DOI: 10.1021/ja01517a031.
[4] JURET P, TANGUY A, GIRARD A, et al. Preliminary trial of 9-hydroxy-2-methyl ellipticinium(NSC 264-137)in advanced human cancers[J]. Eur J Cancer, 1978, 14: 205-206. DOI:10.1016/0014-2964(78)90180-9.
[5] SELVAM P, CLERCP E D, PANNECOUQUE C. Design, synthesis, anti-HIV activity and cytotoxicity of novel schiff’s base of indeo[1,2-b] quinoxalin-11-one derivatives[J]. Int J Drug Des Discov, 2013, 4: 1017-1019.
[6] ZARRANZ B, JASO A, ALDANA I, et al. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives[J]. Bioorg Med Chem, 2004, 12: 3711-3721. DOI:10.1016/j.bmc.2004.04.013.
[7] DALLAVALLE S, FERRARI A, BIASOTTI B, et al. Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity[J]. J Med Chem, 2001, 44: 3264-3674. DOI: 10.1021/jm0108092.
[8] SHARMA V M, PRASANNA P, SESHU K V A, et al. Novel indolo[2,1-b] quinazoline analogus as cytostatic agent: synthesis, biological evaluation and structure-activity relationship[J]. Bioorg Med Chem Lett, 2002, 12: 2303-2307. DOI:10.1016/S0960-894X(02)00431-6.
[9] TSENG C H, TZENG C C,YANG C L, et al. Synthesis and antiproliferative evaluation of certain indeno[1,2-c] quinoline derivatives. part 2[J]. J Med Chem, 2010, 53: 6164-6179. DOI: 10.1021/jm1005447.
Options
Outlines

/

〈 〉